Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Omalizumab
(Xolair (TN))		1件: Omalizumab (Xolair PFS)1件: Omalizumab (Xolair (TN)) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
2Omalizumab (Xolair)1件: Omalizumab (Xolair PFS)1件: Omalizumab (Xolair (TN)) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 65 💬
3Recombinant humanized monoclonal antibody omalizumab to IgE
(Xolair (TN))		1件: Omalizumab (Xolair PFS)1件: Omalizumab (Xolair (TN)) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
4Rituximab combined with Omalizumab
(Xolair (TN))		2件: Omalizumab (Xolair PFS),
Rituximab		2件: Rituximab ,
Omalizumab (Xolair (TN)) 💬 		2件: FCER1A,
MS4A1 💬 		5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 162 💬
5Xolair1件: Omalizumab (Xolair PFS)1件: Omalizumab (Xolair (TN)) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬2件: 46, 299 💬
6Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung1件: Omalizumab (Xolair PFS)1件: Omalizumab (Xolair (TN)) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬